Beyond Compliance: How Decommissioning Serial Numbers Strengthens the Pharma Supply Chain

Decommissioning serial numbers is emerging as a critical best practice in the pharmaceutical industry, enhancing DSCSA compliance and supply chain integrity. By formally retiring products from the supply chain using standardized EPCIS data, manufacturers can prevent fraud, support audits, and improve traceability. This proactive step strengthens patient safety and protects against the re-entry of counterfeit or expired drugs.

• Read more about Beyond Compliance: How Decommissioning Serial Numbers Strengthens the Pharma Supply Chain

The Specialty Pharmacy Squeeze

Specialty pharmacies are under growing financial pressure due to high drug costs, delayed reimbursements, and limited access to support programs like 340B. This cash-flow strain threatens patient access—especially in underserved areas—as some pharmacies are forced to close or exit the market. Addressing the crisis requires faster payments, expanded program access, and reform of pharmacy benefit manager practices to ensure the sustainability of specialty care.

• Read more about The Specialty Pharmacy Squeeze

Reckoning with Waste: Rethinking Medication Management in U.S. Hospitals

Medication waste in hospitals stems from outdated inventory practices and poor visibility. By adopting real-time data and automation, health systems can reduce waste, improve care readiness, and enhance operational efficiency.

• Read more about Reckoning with Waste: Rethinking Medication Management in U.S. Hospitals

Pharmacies, Meet Your Most Underrated Asset

Reverse distribution is pharmacy’s secret weapon—cutting costs, easing compliance burdens, and fueling smarter planning. In this VerifiedRx episode, Inmar and Vizient experts unpack how this often-overlooked process boosts efficiency, supports sustainability, and keeps supply chains strong. A vital listen for health system leaders and pharmacy pros ready to level up logistics strategy.

• Read more about Pharmacies, Meet Your Most Underrated Asset

Why Hospitals are Racing to Secure Essential Medications

Persistent drug shortages are pushing hospitals to rethink supply chains, adopt new technologies, and advocate for policies that ensure critical medication access.

• Read more about Why Hospitals are Racing to Secure Essential Medications

How Life Science Manufacturers Can Tackle the Industry’s Toughest Recall Challenges

Pharmaceutical recalls are complex and high-risk. This article breaks down the top challenges manufacturers face and offers proactive strategies to manage recalls efficiently and protect patient safety.

• Read more about How Life Science Manufacturers Can Tackle the Industry’s Toughest Recall Challenges

Is Your Pharmacy Ready for Medicare Drug Price Negotiation? A Readiness Checklist for Dispensers

Get your pharmacy ready for upcoming Medicare drug price negotiations under the IRA. This checklist covers key MFP requirements, system updates, and compliance tips.

• Read more about Is Your Pharmacy Ready for Medicare Drug Price Negotiation? A Readiness Checklist for Dispensers

Turning Returns Into Results: Key Insights from Inmar’s Rob DeWig on Becker’s Healthcare Podcast

Learn how health systems are using pharmaceutical returns data to drive smarter decisions, cut costs, and improve efficiency. Hear insights from Inmar’s Rob DeWig on Becker’s Healthcare Podcast.

• Read more about Turning Returns Into Results: Key Insights from Inmar’s Rob DeWig on Becker’s Healthcare Podcast

Navigating the Legal Landscape of Pharmaceutical Recalls

This article examines the key legal challenges involved in pharmaceutical recalls, including antitrust compliance, FDA requirements, liability management, and data privacy. It underscores the importance of proactive legal strategies to ensure regulatory adherence, protect public trust, and reduce legal risks throughout the recall process.

• Read more about Navigating the Legal Landscape of Pharmaceutical Recalls